Chicago Partner Rachael Pontikes of Reed Smith’s Life Science Health Industry group will speak at the Food and Drug Law Institute’s (FDLI) Drug Quality Security Act Conference on November 15 in Washington D.C.
The conference will include panels of government regulatory and industry experts discovering current issues surrounding the DQSA’s Title I Compounding Quality Act (CQA) and II Drug Supply Chain Security Act (DSCSA), just four years after being implemented. The conference will also touch on industry updates including, FDA’s Significant Documents and Industry Actions/Reactions on Regulation of Compounding; FDA and Inspections: What to Consider when FDA Visits Your Facility; Licensure of wholesale distributors and 3PL’s: Where does FDA stand, where do states stand, what about VAWD, and what can you do about it?, and so much more.
For a full list of topics, agenda, registration, and additional information please click here.